Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments

Details for Australian Patent Application No. 2009211888 (hide)

Owner Sanofi-Aventis

Inventors Herrmann, Matthias; Heinelt, Uwe; Steinhagen, Henning; Wehner, Volkmar; Schoenafinger, Karl

Agent Watermark

Pub. Number AU-A-2009211888

PCT Pub. Number WO2009/097971

Priority 08290114.1 05.02.08 EP

Filing date 23 January 2009

Wipo publication date 13 August 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/097971 Priority application(s): WO2009/097971

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211890-Imidazopyridazines as PAR1 inhibitors, production thereof, and use thereof as medicaments

2009211887-Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments